¼¼°èÀÇ ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½ÃÀå
Clinical Perinatal Software
»óǰÄÚµå : 1774718
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 470 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀåÀº 2030³â±îÁö 4¾ï 8,050¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 2¾ï 9,680¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 4¾ï 8,050¸¸ ´Þ·¯¿¡ ´ÞÇϰí, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 8.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÅëÇÕ ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î´Â CAGR 10.0%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 9,530¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µ¶¸³Çü ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 6.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8,090¸¸ ´Þ·¯, Áß±¹Àº CAGR 13.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2024³â¿¡ 8,090¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1¾ï 540¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 13.3%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 4.1%¿Í 8.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î°¡ Çö´ëÀÇ »ê¸ð¿Í ½Å»ý¾Æ Äɾ ÇʼöÀûÀÎ Á¸Àç°¡ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î´Â ÀÓ½Å, ºÐ¸¸, »êÈÄ ±â°£ µ¿¾È °¡Àå ¹Î°¨ÇÑ ½Ã±âÀÎ ÀÓ½Å, ºÐ¸¸, »êÈÄ ±â°£ µ¿¾È Ä¡·áÀÇ Áú, ¾ÈÀü¼º, È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â Áß¿äÇÑ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù. »ê¸ð¿Í ½Å»ý¾ÆÀÇ °Ç°­ »óŰ¡ Àü ¼¼°èÀûÀ¸·Î ÁÖ¸ñÀ» ¹ÞÀ¸¸é¼­ ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº ½Ç½Ã°£ ¸ð´ÏÅ͸µ, À§Çè Æò°¡, Áõ°Å¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» °¡´ÉÇÏ°Ô ÇÏ´Â µðÁöÅÐ ¼Ö·ç¼ÇÀ» Á¡Á¡ ´õ ¸¹ÀÌ Ã¤ÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î´Â ÅÂ¾Æ ¸ð´ÏÅ͸µ, ÀüÀÚ ¹®¼­È­, ºÐ¸¸ ÁøÇà ºÐ¼®, ½Å»ý¾Æ Æò°¡¸¦ À§ÇÑ ÅëÇÕ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ÀÓ»óÀǰ¡ ¹ÙÀÌÅ» ÆÄ¶ó¹ÌÅ͸¦ ÃßÀûÇÏ°í °íÀ§Çè »ç·Ê¿¡ Àû±ØÀûÀ¸·Î °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. »ê¸ð ¿¬·ÉÀÇ Áõ°¡, ÀӽŠÇÕº´Áõ ¹ß»ý·ü Áõ°¡, Á¦¿ÕÀý°³À² Áõ°¡¿¡ µû¶ó º´¿øÀº ÀϰüµÈ Áø·á ±âÁØÀ» º¸ÀåÇϰí, ¿À·ù¸¦ ÁÙÀ̰í, ÀÓ»ó ¿öÅ©Ç÷ο츦 È¿À²ÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ê¸ð¿Í žÆÀÇ µ¥ÀÌÅ͸¦ Áß¾Ó ÁýÁßÈ­Çϰí, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)¿¡ ÅëÇÕÇϰí, ÀÚµ¿È­µÈ ¾Ë¸²À» Á¦°øÇÏ´Â ±â´ÉÀº Áø·á Á¶Á¤°ú ÀÓ»ó °á°ú¸¦ ¸ðµÎ °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº »êºÎÀΰú ÀÇ»ç¿Í Á¶»ê»ç»Ó¸¸ ¾Æ´Ï¶ó »ê¸ð¿Í žÆÀÇ Áú ÁöÇ¥ °³¼±°ú ±ÔÁ¦ Áؼö¿¡ ÁßÁ¡À» µÎ°í ÀÖ´Â º´¿ø °ü¸®ÀÚ¿¡°Ôµµ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀü°ú ÅëÇÕ ´É·ÂÀº ÁÖ»ê±â ½Ã½ºÅÛÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº »óÈ£¿î¿ë¼º, ºÐ¼® ¹× »ç¿ëÀÚ Á᫐ ±â¼ú ±â´ÉÀÇ ¹ßÀüÀ¸·Î ºü¸£°Ô º¯È­Çϰí ÀÖ½À´Ï´Ù. ÃֽŠ½Ã½ºÅÛÀº EHR, ¹æ»ç¼± Á¤º¸ ½Ã½ºÅÛ(RIS), °Ë»ç Á¤º¸ ½Ã½ºÅÛ(LIS)°úÀÇ °ß°íÇÑ ÅëÇÕÀ» Á¦°øÇÏ¿© Æ÷°ýÀûÀ̰í ÀϰüµÈ ȯÀÚ µ¥ÀÌÅÍ »ýŰ踦 º¸ÀåÇÕ´Ï´Ù. ½Ç½Ã°£ ÅÂ¾Æ ½É¹Ú¼ö ÇØ¼®, ºÐ¸¸ ÁøÇà ÃßÀû, »ê¸ð Ȱ·Â ¡ÈÄ ¸ð´ÏÅ͸µ, AI Áö¿ø ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø°ú °°Àº °í±Þ ±â´ÉÀº Ä¡·áÀÇ Á¤È®¼ºÀ» ³ôÀÔ´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ µµ±¸ ¹× ¹«¼± ÅÂ¾Æ ¼¾¼­¿Í °°Àº Çõ½ÅÀº Áö¼ÓÀûÀÎ µ¥ÀÌÅÍ ¼öÁý°ú ÀÓ»óÀÇÀÇ ¸ð´ÏÅ͸µÀ» º¸ÀåÇϸ鼭 ȯÀÚÀÇ À̵¿¼º°ú Æí¾ÈÇÔÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒÇÁÆ®¿þ¾î Ç÷§ÆûÀº ¿¹Ãø ºÐ¼® ¹× ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» ÅëÇØ ÅÂ¾Æ °íÅë, ÀÚ°£ÀüÁõ, Á¶»ê°ú °°Àº ÇÕº´ÁõÀ» ³ªÅ¸³»´Â ÆÐÅÏÀ» °¨ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Àü°³ ¸ðµ¨, ¸ð¹ÙÀÏ Á¢±Ù¼º, »ç¿ëÀÚ Á¤ÀÇ °¡´ÉÇÑ ´ë½Ãº¸µå´Â µ¥ÀÌÅÍ Á¢±Ù¼º°ú ´ÙÁ÷Á¾ ÆÀ °£ÀÇ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ, ³»ÀåµÈ ÄÄÇöóÀ̾𽺠µµ±¸´Â ±¹Á¦ Ç¥ÁØ¿¡ ºÎÇÕÇÏ´Â ¹®¼­È­ ¹× ÀÇ·á¹ýÀû °¨»ç ÃßÀûÀ» ¿ëÀÌÇÏ°Ô ÇØÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû ¹ßÀüÀ¸·Î ÀÎÇØ ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î´Â ÁßȯÀÚ Ä¡·á ½Ã³ª¸®¿À¸¦ À§ÇÑ ¿ªµ¿ÀûÀÎ ½Ç½Ã°£ Áö¿ø ½Ã½ºÅÛÀ¸·Î º¯¸ðÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå Çü¼º¿¡ ÀÖ¾î ÀÇ·á±â°ü ¼ö¿ä, Á¤Ã¥Àû Àǹ«, Àα¸ µ¿ÇâÀº ¾î¶² ¿ªÇÒÀ» ÇÒ °ÍÀΰ¡?

Àü ¼¼°èÀûÀ¸·Î ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾îÀÇ º¸±ÞÀº ÀÇ·á±â°üÀÇ ¼ö¿ä, ÁøÈ­ÇÏ´Â Á¤Ã¥ ÇÁ·¹ÀÓ¿öÅ©, Àα¸Åë°èÇÐÀû º¯È­ µîÀÌ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÇ·á ±â°ü, ƯÈ÷ »êºÎÀΰú º´¿ø, ½Å»ý¾Æ ÁßȯÀÚ½Ç(NICU), ºÐ¸¸ ¼¾ÅÍ´Â Áø·áÀÇ Áú°ú ȯÀÚ ¾ÈÀüÀ» °³¼±Çϱâ À§ÇØ µðÁöÅÐ Çõ½Å ³ë·ÂÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ½À´Ï´Ù. ÀÓ»êºÎ °Ç°­ °³¼±, ÀÎÁõ ¿ä°Ç ¹× ±¹°¡ ǰÁú ÇÁ·Î±×·¥¿¡ ´ëÇÑ Á¤ºÎÀÇ Àǹ«´Â º´¿øÀÌ ÁÖ»ê±â ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» äÅÃÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ µî¿¡¼­´Â Meaningful Use ±âÁذú °øµ¿À§¿øÈ¸ÀÇ ±Ç°í¿¡ µû¶ó ¼ÒÇÁÆ®¿þ¾î µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼­µµ À¯»çÇÑ ³ë·ÂÀÌ È®»êµÇ°í ÀÖ½À´Ï´Ù. »ýȰ½À°üÀÇ º¯È­, º¸Á¶»ý½Ä¼ú, »ê¸ð ¿¬·ÉÀÇ Áö¿¬ µîÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î °íÀ§Çè ÀÓ½ÅÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¾ÇÕÀûÀÎ ÁÖ»ê±â µ¥ÀÌÅÍ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ °³¹ßµµ»ó±¹ÀÇ »ê¸ð »ç¸Á·ü°ú ½Å»ý¾Æ »ç¸Á·ü °¨¼Ò¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ±¹Á¦ÀûÀÎ ÀÚ±Ý Áö¿ø°ú ¹Î°ü ÆÄÆ®³Ê½ÊÀ» ÅëÇÑ ±â¼ú µµÀÔÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á Àη ºÎÁ·, ƯÈ÷ ³óÃÌ ¹× ¿Üµý Áö¿ª¿¡¼­ÀÇ Àη ºÎÁ·µµ ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ È¿À²ÀûÀÎ ÀÇ·á ¼­ºñ½º Á¦°øÀ» Áö¿øÇϰí ÀÓ»óÀû ºÎ´ãÀ» ÁÙ¿©ÁÖ´Â µðÁöÅÐ µµ±¸¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú °³¹ß, ÃÖÁ¾»ç¿ëÀÚÀÇ ¿ä±¸, ÁøÈ­ÇÏ´Â ÀÓ»ó ¹× °ü¸® ¿ä±¸»çÇ×°ú Á÷°áµÇ´Â ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ»ê±â ÀÇ·áÀÇ º¹À⼺ Áõ°¡¿Í Á¤È®ÇÑ ½Ç½Ã°£ ÀÓ»óÀû ÆÇ´Ü Áö¿øÀÇ Çʿ伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó º´¿øÀº AI ÅëÇÕ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ, ¿ø°Ý ÅÂ¾Æ ¸ð´ÏÅ͸µ, ±¤¹üÀ§ÇÑ º´¿ø Á¤º¸ ½Ã½ºÅÛ°úÀÇ »óÈ£¿î¿ë¼º µî ÷´Ü µðÁöÅÐ ¼Ö·ç¼ÇÀ» µµÀÔÇÒ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ±â´É°ú ÀÓ»óÀû À¯¿ë¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ǰÁú ÃøÁ¤ ±âÁØ, ȯÀÚ ¾ÈÀü, ÀÓ»ó ¿öÅ©Ç÷οìÀÇ È¿À²¼º¿¡ ´ëÇÑ ÀÇ·á±â°üÀÇ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ÒÇÁÆ®¿þ¾î µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. °íÀ§Çè ÀÓ½Å, Àӽżº ´ç´¢, °íÇ÷¾Ð, Á¶»ê°ú °°Àº ÇÕº´ÁõÀÌ Àü ¼¼°èÀûÀ¸·Î È®»êµÇ¸é¼­ ¿¹Ãø ¹× ¿¹¹æÀû ÁÖ»ê±â ¸ð´ÏÅ͸µ µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ºÐ¸¸ ÀÎÇÁ¶ó È®´ë¿Í º´¿ø ȯ°æ¿¡¼­ÀÇ ºÐ¸¸ °Ç¼ö Áõ°¡´Â ½ÃÀå Àúº¯À» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. °¡Ä¡ ±â¹Ý ÀÇ·á ¸ðµ¨ÀÇ Ã¤Åà Áõ°¡, Á¤ºÎ Áö¿ø±Ý, µðÁöÅÐ »ê¸ð °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡´Â ½ÃÀå ħÅõ¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, »ê¸ð¿Í ½Å»ý¾ÆÀÇ °Ç°­ °á°ú°¡ Àü¹ÝÀûÀÎ °Ç°­ °ü¸®ÀÇ ÁúÀ» ³ªÅ¸³»´Â ÁöÇ¥·Î °­Á¶µÇ¸é¼­ ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î´Â Àü ¼¼°è °ø°ø ¹× ¹Î°£ ÀÇ·á ½Ã½ºÅÛ¿¡¼­ Àü·«Àû ÅõÀÚ·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(ÅëÇÕÇü ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î, µ¶¸³Çü ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î), Àü°³ ÇüÅÂ(¿ÂÇÁ·¹¹Ì½ºÇü Àü°³, Ŭ¶ó¿ìµå ±â¹Ý Àü°³), ¿ëµµ(ÅÂ¾Æ ¸ð´ÏÅÍ µ¥ÀÌÅÍ ¼­ºñ½º ¿ëµµ, ¿öÅ©ÇÃ·Î¿ì °ü¸® ¿ëµµ, ȯÀÚ ´ÙÅ¥¸àÅ×ÀÌ¼Ç ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø ÃÖÁ¾ ¿ëµµ, »ê°ú Ŭ¸®´Ð ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Clinical Perinatal Software Market to Reach US$480.5 Million by 2030

The global market for Clinical Perinatal Software estimated at US$296.8 Million in the year 2024, is expected to reach US$480.5 Million by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Integrated Clinical Perinatal Software, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$295.3 Million by the end of the analysis period. Growth in the Standalone Clinical Perinatal Software segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$80.9 Million While China is Forecast to Grow at 13.3% CAGR

The Clinical Perinatal Software market in the U.S. is estimated at US$80.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$105.4 Million by the year 2030 trailing a CAGR of 13.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Clinical Perinatal Software Market - Key Trends & Drivers Summarized

Why Is Clinical Perinatal Software Becoming Essential in Modern Maternity and Neonatal Care?

Clinical perinatal software has become a critical tool in enhancing the quality, safety, and efficiency of care during the most delicate stages of life-pregnancy, labor, delivery, and the immediate postnatal period. As maternal and neonatal health outcomes gain global attention, healthcare providers are increasingly adopting digital solutions that allow for real-time monitoring, risk assessment, and evidence-based decision-making. Clinical perinatal software offers integrated solutions for fetal monitoring, electronic documentation, labor progression analysis, and neonatal assessments, supporting clinicians in tracking vital parameters and intervening proactively in high-risk cases. With rising maternal age, higher incidence of pregnancy complications, and increasing cesarean rates, hospitals are relying more on perinatal software to ensure consistent care standards, reduce errors, and manage clinical workflows efficiently. Moreover, the ability to centralize maternal and fetal data, integrate it into electronic health records (EHRs), and provide automated alerts enhances both care coordination and clinical outcomes. These systems are becoming indispensable not just for obstetricians and midwives but also for hospital administrators focused on improving maternal care quality metrics and regulatory compliance.

How Are Technological Advancements and Integration Capabilities Transforming Perinatal Systems?

The clinical perinatal software market is being rapidly reshaped by advancements in interoperability, analytics, and user-centric technology features. Modern systems offer robust integration with EHRs, radiology information systems (RIS), and laboratory information systems (LIS), ensuring a comprehensive and cohesive patient data ecosystem. Advanced features such as real-time fetal heart rate interpretation, labor progression tracking, maternal vital sign monitoring, and AI-assisted clinical decision support are enhancing care precision. Innovations like remote monitoring tools and wireless fetal sensors are enabling enhanced mobility and comfort for patients, while ensuring continuous data capture and clinician oversight. Software platforms are also incorporating predictive analytics and machine learning algorithms to detect patterns indicative of complications such as fetal distress, preeclampsia, or preterm labor. Cloud-based deployment models, mobile accessibility, and customizable dashboards are improving data accessibility and communication among multidisciplinary teams. Furthermore, built-in compliance tools ensure that documentation aligns with international standards and facilitates medico-legal audit trails. These technological advancements are transforming clinical perinatal software into a dynamic, real-time support system for critical care scenarios.

What Role Do Institutional Demand, Policy Mandates, and Demographic Trends Play in Shaping Market Growth?

Institutional demand, evolving policy frameworks, and demographic shifts are major forces influencing the adoption of clinical perinatal software globally. Healthcare institutions-particularly maternity hospitals, neonatal intensive care units (NICUs), and birthing centers-are prioritizing digital transformation initiatives to improve care quality and patient safety. Government mandates for maternal health improvement, accreditation requirements, and national quality programs are encouraging hospitals to adopt perinatal monitoring systems. In countries like the United States, Meaningful Use standards and Joint Commission recommendations have accelerated software implementation, while similar initiatives are gaining ground across Europe, Asia-Pacific, and Latin America. The global rise in high-risk pregnancies due to lifestyle disorders, assisted reproductive technologies, and delayed maternal age is further driving demand for comprehensive perinatal data management solutions. Moreover, the increasing focus on reducing maternal and neonatal mortality-particularly in developing regions-has led to international funding and public-private partnerships promoting technology adoption. Healthcare workforce shortages, especially in rural and remote settings, are also prompting providers to invest in digital tools that support efficient care delivery and reduce clinical burdens.

What Are the Key Factors Driving the Growth of the Clinical Perinatal Software Market?

The growth in the clinical perinatal software market is driven by several factors directly tied to technology development, end-user needs, and evolving clinical and administrative requirements. The increasing complexity of perinatal care and the need for accurate, real-time clinical decision support are compelling hospitals to adopt advanced digital solutions. Continuous technological improvements-such as AI-integrated monitoring systems, remote fetal surveillance, and interoperability with broader hospital information systems-are enhancing software capabilities and clinical utility. Rising institutional focus on quality metrics, patient safety, and clinical workflow efficiency is also accelerating software implementation. The growing global prevalence of high-risk pregnancies and complications such as gestational diabetes, hypertension, and preterm birth is driving the demand for predictive and proactive perinatal monitoring tools. Additionally, the expansion of maternity care infrastructure in emerging markets and the rising number of births in hospital settings are widening the market base. The increasing adoption of value-based healthcare models, supportive government funding, and growing awareness of digital maternal health solutions are further boosting market penetration. Lastly, the growing emphasis on maternal and neonatal health outcomes as indicators of overall healthcare quality is positioning clinical perinatal software as a strategic investment in both public and private health systems worldwide.

SCOPE OF STUDY:

The report analyzes the Clinical Perinatal Software market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Integrated Clinical Perinatal Software, Standalone Clinical Perinatal Software); Deployment Mode (On-premises Deployment, Cloud-based Deployment); Application (Fetal monitor Data Services Application, Workflow Management Application, Patient Documentation Application); End-Use (Hospitals End-Use, Maternity Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â